Generation and Characterization of a Protective Monoclonal Antibody to Pseudomonas aeruginosa PcrV
Dara W. Frank, Amy J. Vallis, Jeanine P. Wiener‐Kronish, Arup Roy‐Burman, Edward G. Spack, Brian P. Mullaney, Mehdi Megdoud, James D. Marks, Robert B. Fritz, Teiji Sawa · The Journal of Infectious Diseases · 2002
Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.
The Journal of Infectious Diseases · Oxford University Press · article · 2002
Abstract
Pseudomonas aeruginosa is a gram-negative pathogen causing life-threatening infections. Lung injury and the development of sepsis depend largely on the expression of type III secretion system (TTSS) virulence. TTSS functions as a molecular syringe to deliver toxins directly to the cytosol of cells, inhibit innate immune mechanisms, and prevent bacterial clearance. Polyclonal antibodies that bind to PcrV of P. aeruginosa inhibit the delivery of type III toxins and enhance the clearance of bacteria during acute lung infections. PcrV is a homologue of LcrV, a protective antigen in the Yersinia TTSS and an integral component of TTSS.
In this study, a murine monoclonal antibody (MAb) to PcrV was generated: MAb 166, which is protective against P. aeruginosa when coinstilled with the bacterial inoculum or intraperitoneally transferred to mice. Fab fragments from MAb 166 prevent sepsis and death. The epitope bound by MAb 166 was mapped to the carboxyl-terminus of PcrV.
Open the resolved locator · 10.1086/341069
Metadata licence: OpenAlex metadata (CC0)